| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research | Officer Level 14 | EVP, Research +1 more
1 company
Eric Swayze is EVP Research at IONS. From January 2020 to October 2026, the filings on record show 0 open-market purchases and 24 sales. Eric Swayze's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $16K at current prices.
Historically, Eric Swayze's trades have earned a middling insider score of 67/100 across 24 rated trades. Over a 12-month horizon, 63.2% of those trades were profitable, with an average 12-month return of -5.1%.
The IONS filings lean toward selling, a net 175,425 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 1,367 | $32.31 | $44,162.03 | -2.8% | -0.6% | +159.2% | |
| Jan 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 7,176 | $32.84 | $235,678.22 | -97.5% | -12.2% | +136.5% | |
| Nov 12, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell10b5-1 | 1,194 | $37.92 | $45,277.67 | -3.4% | -16.7% | +92.4% | |
| Oct 16, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 53 | $38.31 | $2,030.59 | -25.2% | -16.5% | +86.6% | |
| Feb 2, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell10b5-1 | 12,680 | $51.63 | $654,709.40 | -27.0% | -13.4% | -35.9% | |
| Jan 17, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 6,305 | $50.42 | $317,879.19 | -98.7% | -19.0% | -37.1% | |
| Dec 28, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE10b5-1 | 27,100 | $50.19 | $1,360,081.25 | -45.5% | -11.6% | -28.9% | |
| Oct 17, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 52 | $47.95 | $2,493.35 | -41.6% | +5.2% | -19.3% | |
| Feb 6, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 1,815 | $40.79 | $74,031.31 | -5.4% | -13.1% | +21.3% | |
| Jan 18, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 5,631 | $39.74 | $223,799.59 | -15.8% | -8.6% | +27.2% |